Gilead says its coronavirus treatment reduces risk of death in very sick patients; German company says they will be ready to seek approval for COVID-19 vaccine by end of year
Gilead says its coronavirus treatment reduces risk of death in very sick patients; German company says they will be ready to seek approval for COVID-19 vaccine by end of year